Long-Term Trazodone Use and Cognition: A Potential Therapeutic Role for Slow-Wave Sleep Enhancers

Manuscript Number: 

18-1145

Author(s): 
Elissaios Karageorgiou, Andrew D. Krystal, Alice La, Bruce L. Miller, Thomas C. Neylan, Keith A. Vossel, Christine M. Walsh, Kristine Yaffe

Disclosures

Elissaios Karageorgiou

  • Nothing to Disclose

Andrew D. Krystal

  • Consulting Fees:
    Advisory Board: Adare, Eisai, Ferring, Galderma, Harmony Biosciences, Idorsia, Jazz, Janssen, Takeda, Merck, Neurocrine, Pernix, Physician’s Seal
    Grants
    • Agency: 
      NIH, Janssen, Jazz. Axsome, Reveal Biosensors
      Dates: 
      NIH for last 25 years and currently; Janssen 2014-2017; Axsome: Current Funding; Reveal Biosensors: Current Funding

Alice La

  • Nothing to Disclose

Bruce L. Miller

  • Consulting Fees:
    The Tau Consortium - Scientific Advisor The Larry L. Hillblom Foundation - Medical Advisory Board The Bluefield Project to Cure Frontotemporal Dementia- Internal Advisor University of Washington ADRC - External Advisor Stanford University ADRC - External Advisor Arizona Alzheimer’s Disease Center (ADC) - External Advisor Massachusetts Alzheimer Disease Research Center – External Advisor The Buck Institute for Research on Aging – Scientific Advisor I
    Grants
    • Agency: 
      UCSF/Quest Diagnostics Dementia Pathway Collaboration Research Grant
      Dates: 
      October 12, 2014
    • Agency: 
      Cornell University Subcontract (Grinberg): 1U54NS100717-01
      Dates: 
      September 1, 2018

Thomas C. Neylan

  • Nothing to Disclose

Keith A. Vossel

  • Nothing to Disclose

Christine M. Walsh

  • Nothing to Disclose

Kristine Yaffe

  • Nothing to Disclose